CCM
PCVX icon

Cinctive Capital Management’s Vaxcyte PCVX Stock Holding History

Cinctive Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
17,455
-57,092
-77% -$3.1M 0.04% 325
2026
Q1 		$4.33M Buy
+74,547
New +$4.05M 0.28% 122
2024
Q4 		– Sell
-32,494
Closed -$3.71M – 451
2024
Q3 		$3.71M Buy
+32,494
New +$2.93M 0.2% 163

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cinctive Capital Management's PCVX Position: Q2 2026 in Review

Cinctive Capital Management reduced its Vaxcyte (PCVX) stake by 77% in Q2 2026, selling an estimated $3.1M and leaving 17,455 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #325.

Cinctive Capital Management first reported a position in PCVX in Q3 2024 and has held it in 3 quarters since. The position peaked at $4.33M in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Cinctive Capital Management held 17,455 shares of Vaxcyte worth $1.01M as of Q2 2026.
  • Cinctive Capital Management sold 57,092 Vaxcyte shares in Q2 2026, an estimated $3.1M.
  • Vaxcyte made up 0.04% of Cinctive Capital Management's portfolio in Q2 2026, its #325 holding.
  • Cinctive Capital Management first reported a position in Vaxcyte in Q3 2024 and has held it in 3 quarters since.
  • Cinctive Capital Management's Vaxcyte position peaked at $4.33M in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.